Related Experiment Video

Updated: Sep 18, 2025

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
12:09

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection

Published on: May 2, 2011

43.0K

Improved SARS-CoV-2 vaccine based on intranasally administered replicon RNA

Kenneth Lundstrom1

  • 1PanTherapeutics, Route de Lavaux 49, 1095 Lutry, Switzerland.

Molecular Therapy : the Journal of the American Society of Gene Therapy
|June 25, 2025
PubMed
Summary

No abstract available in PubMed .

More Related Videos

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
09:14

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

Published on: January 26, 2019

11.1K
A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
08:07

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

2.7K

Related Experiment Videos

Last Updated: Sep 18, 2025

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
12:09

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection

Published on: May 2, 2011

43.0K
An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
09:14

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

Published on: January 26, 2019

11.1K
A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
08:07

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

2.7K

Related Concept Videos

Viruses with RNA Genomes01:29

Viruses with RNA Genomes

146
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
146

Articles linked to this work by shared authors, journal, and citation graph.

The XEC Variant: Genomic Evolution, Immune Evasion, and Public Health Implications.

Viruses·2025

Methuselah proteins in Drosophila: Structural and evolutionary insights from mathematical genomics.

Biochemical and biophysical research communications·2025

Viral Vector-Based Cancer Vaccines.

Methods in molecular biology (Clifton, N.J.)·2025

Immunobiology and immunotherapy of COVID-19.

Progress in molecular biology and translational science·2025

Molecular genomic insights into melanoma associated proteins PRAME and BAP1.

Journal of biomolecular structure & dynamics·2025

Self-amplifying RNA virus vectors for drug delivery.

Expert opinion on drug delivery·2025

A complement C5-targeted GalNAc-conjugated siRNA with sustained efficacy in a non-human primate model of IgA nephropathy.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

DC vaccine loaded with Bacteroides fragilis elicits functional cross-reactivity and enhances anti-PD-1 immunotherapy.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

Viral gene replication enhances AAV vector quality and reduces manufacturing costs.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

Unlocking extracellular vesicles-mediated efficient DNA delivery for long-lasting transgene expression.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

The DreAM-plus integrative RNA switch enhances transient AAV expression and reduces side effects of gene editing.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

Human iPSC-derived neural progenitor gene therapy improves outcomes in a neuropathic lysosomal disease.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

Retraction: Bone marrow mesenchymal stem cells alleviate smoke inhalation injury by regulating alveolar macrophage polarization via the CD200-CD200R pathway.

Frontiers in immunology·2026

Splenic neuromodulation as monotherapy and in combination with biologic or targeted synthetic DMARDs for difficult-to-treat rheumatoid arthritis (ConsiderRAte): a randomised, sham-controlled, early feasibility trial.

EClinicalMedicine·2026

Predictors of Treatment Failure and Second-Line Therapy Outcomes After Rezūm Therapy for Benign Prostatic Hyperplasia.

Cureus·2026

Development of tetrahydroquinazoline compounds as Fusion protein inhibitors for the treatment of respiratory syncytial virus.

European journal of medicinal chemistry·2026

From 18F‑MC225 to Conformationally Free Derivatives.

ACS omega·2026

Storage-associated physicochemical changes in extracellular vesicles derived from human mesenchymal stromal cells.

Frontiers in bioengineering and biotechnology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us